GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » Debt-to-EBITDA

Integrum AB (OSTO:INTEG B) Debt-to-EBITDA : 1.72 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Integrum AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrum AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr1.56 Mil. Integrum AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr5.25 Mil. Integrum AB's annualized EBITDA for the quarter that ended in Jan. 2024 was kr3.96 Mil. Integrum AB's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 1.72.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Integrum AB's Debt-to-EBITDA or its related term are showing as below:

OSTO:INTEG B' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.29   Med: -0.13   Max: 24.9
Current: -2.29

During the past 9 years, the highest Debt-to-EBITDA Ratio of Integrum AB was 24.90. The lowest was -2.29. And the median was -0.13.

OSTO:INTEG B's Debt-to-EBITDA is ranked worse than
100% of 435 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs OSTO:INTEG B: -2.29

Integrum AB Debt-to-EBITDA Historical Data

The historical data trend for Integrum AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Debt-to-EBITDA Chart

Integrum AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -0.06 -0.17 -2.00 0.24 -0.39

Integrum AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.23 -0.78 0.26 1.72

Competitive Comparison of Integrum AB's Debt-to-EBITDA

For the Medical Devices subindustry, Integrum AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Integrum AB's Debt-to-EBITDA falls into.



Integrum AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrum AB's Debt-to-EBITDA for the fiscal year that ended in Apr. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.491 + 6.424) / -20.358
=-0.39

Integrum AB's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.557 + 5.248) / 3.964
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


Integrum AB  (OSTO:INTEG B) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Integrum AB Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Integrum AB's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrum AB (OSTO:INTEG B) Business Description

Traded in Other Exchanges
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines